Charging for Investigational Drugs Under an IND: Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 14, 2024
February 16, 2024
e6ac16bc-3e90-4996-b2e5-b9671d33c720
Related Documents
Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers
Guidance DocumentOctober 22, 2025Center for Drug Evaluation and Research
Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products
Guidance DocumentMay 26, 2023Center for Drug Evaluation and Research
Reporting Amount of Listed Drugs and Biological Products Technical Conformance Guide: Guidance for Industry
Guidance DocumentFebruary 26, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.